Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Coronavirus Disease 2019- Using Ascorbic Acid and Zinc Supplementation (COVIDAtoZ) Research Study A Randomized, Open Label Single Center Study

NCT04342728 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT04342728
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04342728 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Coronavirus Disease 2019- Using Ascorbic Acid and Zinc Supplementation (COVIDAtoZ) Research Study A Randomized, Open Label Single Center Study
Lead sponsor
The Cleveland Clinic
Phase
Not applicable
Overall status
Completed
Start date
April 8, 2020
Completion date
February 11, 2021
Enrollment
214 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

corona virus infection, covid